Sales and Marketing

Showing 15 posts of 11524 posts found.

shire_image

Shire’s drug picked up from Baxalta given fast track designation

March 23, 2017 Research and Development, Sales and Marketing Shire, rare diseases

Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …
fda2outsideweb

FDA approves first Parkinson’s treatment in a decade

March 22, 2017 Research and Development, Sales and Marketing FDA, Parkinson's, Xadago

The FDA has approved Xadago (safinamide) as a supplementary treatment for Parkinson’s in patients currently taking levodopa/carbidopa and who are …
shutterstock_291014192

Asia-Pacific NSCLC market to more than double to $6.2bn by 2023

March 21, 2017 Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo

New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …

Biogaran acquires production foothold in Nigeria with Swipha acquisition

March 21, 2017 Manufacturing and Production, Sales and Marketing Biogaran, Swipharma

Biogaran, the French generic manufacturer that is a subsidiary of Servier, has acquired a foothold in Nigeria with a 95% …
thumbs_down

Array BioPharma in disarray over withdrawal of NDA

March 20, 2017 Manufacturing and Production, Sales and Marketing Array Biopharma

Array BioPharma has announced that it has pulled its new drug application (NDA) for its drug, binimetinib, for the treatment …
shutterstock_311949818

Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures

March 20, 2017 Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …
china_wall

China proposes ways to speed up approval for imported drugs

March 20, 2017 Sales and Marketing China, imported drugs

It can currently take up to three or four years for a new drug to reach market in China, slowing …
pakistan-895319_960_720

Pakistan’s problem with diabetes – with 7 million diabetics

March 20, 2017 Medical Communications, Sales and Marketing Pakistan, Sanofi, diabetes

Pakistan is facing an increasing problem with people suffering from diabetes. At a recent conference, the 4th International Diabetes Conference, …
pulmocide-logo

UK biotech Pulmocide secures $30m for inhalable lung disease therapies

March 20, 2017 Research and Development, Sales and Marketing pulmocide, pulmonary aspergillosis, respiratory syncytial virus

Pulmocide, a UK biotech run by a former GlaxoSmithKline scientists and based in London, has secured $30.4 million in Series …
pregnant-1245703_960_720

Pregnancy test pill used through 60s & 70s connected with birth defects

March 20, 2017 Medical Communications, Sales and Marketing Bayer, Primodos

A pregnancy test, named Primodos, which was taken by 1.5 million British mothers and was linked to birth defects, may …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

As another week comes and goes, waves were sent through the industry as Trump announced his pick as the new …
shutterstock_274590824

Ex-Novartis employee found not guilty of deceitful drug advertising

March 17, 2017 Medical Communications, Sales and Marketing Diovan, Novartis, legal

A Tokyo court has ruled finding ex-Novartis employee Nobuo Shirahashi and the company’s Tokyo-based sales arm Novartis Pharma KK not …
anirvan_ghosh

Biogen swoops to appoint Ex-Roche Vice President

March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen

Biogen have appointed Anirvan Ghosh to the position of Senior Vice President of research and Early Development. Ghosh is slated …

NICE reverses decision on medication for relapsing multiple sclerosis

March 16, 2017 Sales and Marketing Biogen, zinbryta

The current topic of discussion regarding NICE is how its recent changes will impact patient access to medicine but, away …
7808465302_a335c6dd4f_o

The rising threat of antibiotic resistance

March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance

Last month, researchers from the University of California, Los Angeles (UCLA) revealed findings that showed that utilising antibiotics in combination …
The Gateway to Local Adoption Series

Latest content